Aldatu Biosciences is helping to overcome HIV drug resistance

Share: Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

After winning the Bertarelli Prize in 2014, Aldatu Biosciences has continued developing their PANDAA technology which aims to improve HIV patient care by detecting antiretroviral drug resistance.  Since then, others have also recognised Aldatu’s potential and they were awarded the Verizon Powerful Answers Award and in 2015 awarded a Direct-to-Phase II Small Business Innovation Research grant for approximately $1,500,000 over two years.

Co-founders, David Raiser and Iain MacLeod, travelled to Botswana to meet researchers at the Harvard AIDS Institute.  We went with them to find out how the Bertarelli Prize helped their businesses grow and how their technology might help HIV patients ensure they are receiving the correct treatment.

Share: Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn